NIMH’s Insel Answers Questions on Stimulus Spending

Tom Insel, MD, Director of the National Institute of Mental Health (NIMH), addressed concerns about how NIMH was prioritizing their spending of their allocated $366 million slice of the ARRA pie. He explained that the funds would be used to jumpstart its strategic plan, support autism and AIDS research, and provide training and support for faculty positions.

As Congress and the country wonder when they will feel the impact of the recent stimulus legislation on the economy, questions are also being raised about how the National Institutes of Health is spending the $10.4 billion it received through the American Recovery and Reinvestment Act (ARRA).

APA, in collaboration with the Ad Hoc Group for Medical Research, cosponsored a congressional briefing featuring Tom Insel, MD, Director of the National Institute of Mental Health (NIMH), to address this issue and share NIMH’s priorities for spending its $366 million slice of the ARRA pie. Insel explained that the institute is using the funds to jumpstart its strategic plan, support autism and AIDS research and provide training and support for faculty positions. NIMH has allocated $60 million to expand its payline, $20 million for administrative and competitive supplements, $157 million for the Challenge and Grand Opportunity grants, $30 million for autism research, $35 million for its new suicide research project with the Army and the Recovery After an Initial Schizophrenic Episode (RAISE) initiative and $5 million on faculty recruitment.